Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3934888 | European Urology Supplements | 2007 | 5 Pages |
Abstract
Median survival benefit after IMT and surgery compared with IMT alone was 8 mo for patients who achieved PR. The resection of tumor residues after PR under IMT seems to extend the long-term survival of patients with mRCC and should be attempted when surgically feasible.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Olaf A. Brinkmann, Michael Semik, Georg Gosherger, Lothar Hertle,